PubMed Health⌕ Search

Biomedical subjects

M Tsukamura

Publications and source records attributed to M Tsukamura.

At least 73 records · Page 4Linked to original sources
PubMed1988

Evidence suggesting that the life span of Mycobacterium avium complex is longer than that of other mycobacteria.

Mycobacterium avium complex strains often contain considerably more numbers of viable bacterial units per mg wet weight than other mycobacteria, especially other slowly growing ones. This finding suggests that the life span of M. avium complex strains is often longer than the life span of other mycobacteria. The other mycobacteria, especially slowly growing ones seem to die more rapidly after their multiplication.

Cell Division↗
PubMed1988

Evidence that antituberculosis drugs are really effective in the treatment of pulmonary infection caused by Mycobacterium avium complex.

Successful chemotherapy of pulmonary disease caused by Mycobacterium avium complex by antituberculosis drugs has been reported by a number of investigators. However, no certain evidence of the efficacy has yet been demonstrated in a controlled clinical trial. The present study has approached this problem in 2 ways: serial analysis of minimal inhibitory concentrations (MIC) during treatment and correlation of response to therapy with initial MIC. It was observed that after administration of antituberculosis drugs (rifampin, isoniazid, kanamycin, enviomycin, and minocycline), MIC values for the M. avium complex strain increased significantly. This change may be considered a result of suppression of relatively susceptible bacteria and as evidence of the efficacy of drugs. Furthermore, a correlation between the MIC values determined before chemotherapy with the conversion of sputum to negative was shown. The M. avium complex strains varied markedly in their susceptibility to antituberculosis drugs, and these susceptibilities were correlated with the chemotherapeutic effect. The fate of patients seemed to be greatly influenced by the susceptibilities of the strains that caused infection.

Antitubercular Agents↗
PubMed1988

Studies on the epidemiology of nontuberculous mycobacteriosis in Japan.

The epidemiology of mycobacterial disease in Japan changed considerably over the period 1971 to 1984. During this time, the incidence of pulmonary disease caused by Mycobacterium tuberculosis has steadily declined; disease caused by M. avium complex has remained stable; disease caused by M. kansasii has increased considerably; and, for the first time, substantial numbers of cases caused by M. szulgai, M. fortuitum, M. chelonae, and M. nonchromogenicum have been reported. From 1981 to 1984 the incidence of pulmonary nontuberculous mycobacterioses (NTM) was estimated at 1.73 +/- 0.25 cases per 100,000 population per year; of these, M. avium complex constituted 1.29 +/- 0.24 and M. kansasii 0.34 +/- 0.11 per 100,000 per year. The prevalence of the NTM was relatively high in southwestern Japan (industrialized, warm climate) and low in northern Japan (rural, cold).

Age Factors↗
PubMed1988

Comparison of antituberculosis drug regimens for lung disease caused by Mycobacterium avium complex.

A total of 123 patients with moderately advanced, cavitary lung disease caused by Mycobacterium avium complex untreated previously received different regimens of antituberculosis agents. The rate of sputum conversion (continuously negative cultures for six months or more) was compared among the regimens. It was shown that the regimens of rifampin + isoniazid + streptomycin and rifampin + isoniazid + enviomycin were superior to the regimens of streptomycin + isoniazid + p-aminosalicylate, isoniazid alone or isoniazid + p-aminosalicylate. This finding demonstrated that the regimens including rifampin, isoniazid and streptomycin or enviomycin were really effective in the initial treatment of lung disease caused by M avium complex.

Aminosalicylic Acid↗